Cargando…
Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis
BACKGROUND: The dioxin (AhR) receptor can have oncogenic or tumor suppressor activities depending on the phenotype of the target cell. We have shown that AhR knockdown promotes melanoma primary tumorigenesis and lung metastasis in the mouse and that human metastatic melanomas had reduced AhR levels...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524442/ https://www.ncbi.nlm.nih.gov/pubmed/26242870 http://dx.doi.org/10.1186/s12943-015-0419-9 |
_version_ | 1782384196439769088 |
---|---|
author | Contador-Troca, María Alvarez-Barrientos, Alberto Merino, Jaime M. Morales-Hernández, Antonio Rodríguez, María I. Rey-Barroso, Javier Barrasa, Eva Cerezo-Guisado, María I. Catalina-Fernández, Inmaculada Sáenz-Santamaría, Javier Oliver, Francisco J. Fernandez-Salguero, Pedro M. |
author_facet | Contador-Troca, María Alvarez-Barrientos, Alberto Merino, Jaime M. Morales-Hernández, Antonio Rodríguez, María I. Rey-Barroso, Javier Barrasa, Eva Cerezo-Guisado, María I. Catalina-Fernández, Inmaculada Sáenz-Santamaría, Javier Oliver, Francisco J. Fernandez-Salguero, Pedro M. |
author_sort | Contador-Troca, María |
collection | PubMed |
description | BACKGROUND: The dioxin (AhR) receptor can have oncogenic or tumor suppressor activities depending on the phenotype of the target cell. We have shown that AhR knockdown promotes melanoma primary tumorigenesis and lung metastasis in the mouse and that human metastatic melanomas had reduced AhR levels with respect to benign nevi. METHODS: Mouse melanoma B16F10 cells were engineered by retroviral transduction to stably downregulate AhR expression, Aldh1a1 expression or both. They were characterized for Aldh1a1 activity, stem cell markers and migration and invasion in vitro. Their tumorigenicity in vivo was analyzed using xenografts and lung metastasis assays as well as in vivo imaging. RESULTS: Depletion of aldehyde dehydrogenase 1a1 (Aldh1a1) impairs the pro-tumorigenic and pro-metastatic advantage of melanoma cells lacking AhR expression (sh-AhR). Thus, Aldh1a1 knockdown in sh-AhR cells (sh-AhR + sh-Aldh1a1) diminished their migration and invasion potentials and blocked tumor growth and metastasis to the lungs in immunocompetent AhR+/+ recipient mice. However, Aldh1a1 downmodulation in AhR-expressing B16F10 cells did not significantly affect tumor growth in vivo. Aldh1a1 knockdown reduced the high levels of CD133(+)/CD29(+)/CD44(+) cells, melanosphere size and the expression of the pluripotency marker Sox2 in sh-AhR cells. Interestingly, Sox2 increased Aldh1a1 expression in sh-AhR but not in sh-AhR + sh-Aldh1a1 cells, suggesting that Aldh1a1 and Sox2 may be co-regulated in melanoma cells. In vivo imaging revealed that mice inoculated with AhR + Aldh1a1 knockdown cells had reduced tumor burden and enhanced survival than those receiving Aldh1a1-expressing sh-AhR cells. CONCLUSIONS: Aldh1a1 overactivation in an AhR-deficient background enhances melanoma progression. Since AhR may antagonize the protumoral effects of Aldh1a1, the AhR(low)-Aldh1a1(high) phenotype could be indicative of bad outcome in melanoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0419-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4524442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-45244422015-08-05 Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis Contador-Troca, María Alvarez-Barrientos, Alberto Merino, Jaime M. Morales-Hernández, Antonio Rodríguez, María I. Rey-Barroso, Javier Barrasa, Eva Cerezo-Guisado, María I. Catalina-Fernández, Inmaculada Sáenz-Santamaría, Javier Oliver, Francisco J. Fernandez-Salguero, Pedro M. Mol Cancer Research BACKGROUND: The dioxin (AhR) receptor can have oncogenic or tumor suppressor activities depending on the phenotype of the target cell. We have shown that AhR knockdown promotes melanoma primary tumorigenesis and lung metastasis in the mouse and that human metastatic melanomas had reduced AhR levels with respect to benign nevi. METHODS: Mouse melanoma B16F10 cells were engineered by retroviral transduction to stably downregulate AhR expression, Aldh1a1 expression or both. They were characterized for Aldh1a1 activity, stem cell markers and migration and invasion in vitro. Their tumorigenicity in vivo was analyzed using xenografts and lung metastasis assays as well as in vivo imaging. RESULTS: Depletion of aldehyde dehydrogenase 1a1 (Aldh1a1) impairs the pro-tumorigenic and pro-metastatic advantage of melanoma cells lacking AhR expression (sh-AhR). Thus, Aldh1a1 knockdown in sh-AhR cells (sh-AhR + sh-Aldh1a1) diminished their migration and invasion potentials and blocked tumor growth and metastasis to the lungs in immunocompetent AhR+/+ recipient mice. However, Aldh1a1 downmodulation in AhR-expressing B16F10 cells did not significantly affect tumor growth in vivo. Aldh1a1 knockdown reduced the high levels of CD133(+)/CD29(+)/CD44(+) cells, melanosphere size and the expression of the pluripotency marker Sox2 in sh-AhR cells. Interestingly, Sox2 increased Aldh1a1 expression in sh-AhR but not in sh-AhR + sh-Aldh1a1 cells, suggesting that Aldh1a1 and Sox2 may be co-regulated in melanoma cells. In vivo imaging revealed that mice inoculated with AhR + Aldh1a1 knockdown cells had reduced tumor burden and enhanced survival than those receiving Aldh1a1-expressing sh-AhR cells. CONCLUSIONS: Aldh1a1 overactivation in an AhR-deficient background enhances melanoma progression. Since AhR may antagonize the protumoral effects of Aldh1a1, the AhR(low)-Aldh1a1(high) phenotype could be indicative of bad outcome in melanoma. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12943-015-0419-9) contains supplementary material, which is available to authorized users. BioMed Central 2015-08-05 /pmc/articles/PMC4524442/ /pubmed/26242870 http://dx.doi.org/10.1186/s12943-015-0419-9 Text en © Contador-Troca et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Contador-Troca, María Alvarez-Barrientos, Alberto Merino, Jaime M. Morales-Hernández, Antonio Rodríguez, María I. Rey-Barroso, Javier Barrasa, Eva Cerezo-Guisado, María I. Catalina-Fernández, Inmaculada Sáenz-Santamaría, Javier Oliver, Francisco J. Fernandez-Salguero, Pedro M. Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
title | Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
title_full | Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
title_fullStr | Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
title_full_unstemmed | Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
title_short | Dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
title_sort | dioxin receptor regulates aldehyde dehydrogenase to block melanoma tumorigenesis and metastasis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524442/ https://www.ncbi.nlm.nih.gov/pubmed/26242870 http://dx.doi.org/10.1186/s12943-015-0419-9 |
work_keys_str_mv | AT contadortrocamaria dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT alvarezbarrientosalberto dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT merinojaimem dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT moraleshernandezantonio dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT rodriguezmariai dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT reybarrosojavier dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT barrasaeva dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT cerezoguisadomariai dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT catalinafernandezinmaculada dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT saenzsantamariajavier dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT oliverfranciscoj dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis AT fernandezsalgueropedrom dioxinreceptorregulatesaldehydedehydrogenasetoblockmelanomatumorigenesisandmetastasis |